A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

February 29, 2004

Conditions

Idiopathic Thrombocytopenic Purpura (ITP)

Interventions

DRUG

Rituximab

Trial Locations (1)

Weill Medical College of Cornell University Division of Pediatric Hematology-Oncology, New York